JPWO2020176894A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020176894A5
JPWO2020176894A5 JP2021550178A JP2021550178A JPWO2020176894A5 JP WO2020176894 A5 JPWO2020176894 A5 JP WO2020176894A5 JP 2021550178 A JP2021550178 A JP 2021550178A JP 2021550178 A JP2021550178 A JP 2021550178A JP WO2020176894 A5 JPWO2020176894 A5 JP WO2020176894A5
Authority
JP
Japan
Prior art keywords
iron
aqueous
pharmaceutical composition
concentration
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021550178A
Other languages
English (en)
Japanese (ja)
Other versions
JP7320611B2 (ja
JP2022522009A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020517 external-priority patent/WO2020176894A1/en
Publication of JP2022522009A publication Critical patent/JP2022522009A/ja
Publication of JPWO2020176894A5 publication Critical patent/JPWO2020176894A5/ja
Priority to JP2023118851A priority Critical patent/JP7646750B2/ja
Application granted granted Critical
Publication of JP7320611B2 publication Critical patent/JP7320611B2/ja
Priority to JP2025033475A priority patent/JP2025084949A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021550178A 2019-02-28 2020-02-28 新規鉄組成物及びその製造方法と使用方法 Active JP7320611B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023118851A JP7646750B2 (ja) 2019-02-28 2023-07-21 新規鉄組成物及びその製造方法と使用方法
JP2025033475A JP2025084949A (ja) 2019-02-28 2025-03-04 新規鉄組成物及びその製造方法と使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962812028P 2019-02-28 2019-02-28
US62/812,028 2019-02-28
PCT/US2020/020517 WO2020176894A1 (en) 2019-02-28 2020-02-28 Novel iron compositions and methods of making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023118851A Division JP7646750B2 (ja) 2019-02-28 2023-07-21 新規鉄組成物及びその製造方法と使用方法

Publications (3)

Publication Number Publication Date
JP2022522009A JP2022522009A (ja) 2022-04-13
JPWO2020176894A5 true JPWO2020176894A5 (enExample) 2022-10-05
JP7320611B2 JP7320611B2 (ja) 2023-08-03

Family

ID=70190086

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021550178A Active JP7320611B2 (ja) 2019-02-28 2020-02-28 新規鉄組成物及びその製造方法と使用方法
JP2023118851A Active JP7646750B2 (ja) 2019-02-28 2023-07-21 新規鉄組成物及びその製造方法と使用方法
JP2025033475A Pending JP2025084949A (ja) 2019-02-28 2025-03-04 新規鉄組成物及びその製造方法と使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023118851A Active JP7646750B2 (ja) 2019-02-28 2023-07-21 新規鉄組成物及びその製造方法と使用方法
JP2025033475A Pending JP2025084949A (ja) 2019-02-28 2025-03-04 新規鉄組成物及びその製造方法と使用方法

Country Status (20)

Country Link
US (4) US11292813B2 (enExample)
EP (2) EP3930686B1 (enExample)
JP (3) JP7320611B2 (enExample)
KR (1) KR20210133243A (enExample)
CN (2) CN113825496B (enExample)
AU (2) AU2020229381A1 (enExample)
CA (1) CA3131596A1 (enExample)
DK (1) DK3930686T3 (enExample)
ES (1) ES2955019T3 (enExample)
FI (1) FI3930686T3 (enExample)
HR (1) HRP20230989T1 (enExample)
HU (1) HUE063182T2 (enExample)
LT (1) LT3930686T (enExample)
PL (1) PL3930686T3 (enExample)
PT (1) PT3930686T (enExample)
RS (1) RS64652B1 (enExample)
SG (1) SG11202109323UA (enExample)
SI (1) SI3930686T1 (enExample)
SM (1) SMT202300276T1 (enExample)
WO (1) WO2020176894A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220079984A1 (en) * 2020-09-11 2022-03-17 Renibus Therapeutics, Inc. Method for treating cancer with kidney protection
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof
CN115969714B (zh) * 2022-11-03 2025-03-11 华熙生物科技股份有限公司 具有光谱选择性的防晒组合物及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE862482C (de) 1950-05-14 1953-01-12 Merck Chem Fab E Verfahren zur Darstellung haltbarer, injizierbarer Loesungen von Salzen des dreiwertigen Eisens
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
EP1347795A2 (en) * 2000-12-20 2003-10-01 Dialysis Solutions Inc. Sterile low bicarbonate dialysis concentrate solutions
MXPA05002159A (es) * 2002-08-26 2005-12-05 Vifor Int Ag Prueba de bioquivalencia para formulaciones que contienen hierro.
AU2004317858B2 (en) * 2004-03-16 2011-04-21 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
EP1819720B1 (en) 2004-12-06 2013-05-15 Emcure Pharmaceuticals Limited A cost-effective process for preparation of manufacture of iron sucrose
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
CN100528237C (zh) 2005-04-26 2009-08-19 重庆医药工业研究院有限责任公司 多核的氢氧化铁-糖复合物的制备方法
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
AU2007307111B2 (en) 2006-10-04 2012-03-08 Mallinckrodt Hospital Products IP Limited High-purity large-scale preparation of stannsoporfin
EP1947120A1 (de) 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
IN269965B (enExample) 2007-06-25 2015-11-27 Claris Lifescienses Ltd
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
US20120052135A1 (en) * 2009-03-02 2012-03-01 Vifor (International) Ag Phosphate Adsorbent
CN102451185A (zh) * 2010-10-19 2012-05-16 长春纳米生技公司 金属离子纳米簇组合物
EP2548562A1 (de) 2011-07-18 2013-01-23 SeBo GmbH Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern
EP2647389A1 (en) * 2012-04-04 2013-10-09 Charité - Universitätsmedizin Berlin Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
CN103340827B (zh) 2013-07-16 2014-12-10 成都天台山制药有限公司 蔗糖铁注射液及其制法
CN104558064A (zh) 2013-10-29 2015-04-29 北京京卫信康医药科技发展有限公司 蔗糖铁的制备方法
IN2013CH05383A (enExample) 2013-11-21 2015-08-28 Reddy’S Lab Ltd Dr
CN104098616B (zh) 2014-05-27 2016-04-20 广西壮族自治区化工研究院 一种蔗糖铁的制备方法
NZ729754A (en) * 2014-09-29 2023-01-27 Hutchinson Fred Cancer Res Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
WO2017165692A1 (en) * 2016-03-23 2017-09-28 Fred Hutchinson Cancer Research Center Compounds linked with a saccharide metal complex and uses thereof
US20190358242A1 (en) 2017-02-08 2019-11-28 Fred Hutchinson Cancer Research Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
RS66675B1 (sr) 2017-09-11 2025-05-30 Pharmacosmos Holding As Kompleksna jedinjenja gvožđa za terapeutsku upotrebu
CN109912675B (zh) 2017-12-13 2020-09-15 北京市林业果树科学研究院 一种蔗糖亚铁及其制备方法
CN110063965A (zh) 2019-06-04 2019-07-30 吉林省富生医疗器械有限公司 一种血液透析浓缩物
CN112315902B (zh) 2019-08-05 2022-05-13 南京恒生制药有限公司 一种低易变铁含量蔗糖铁注射液制备方法
CN112168844A (zh) 2020-09-29 2021-01-05 神奈纳米医药技术(珠海)有限公司 一种氢氧化铁碳水化合物复合物的制备方法
MX2023003647A (es) 2020-09-29 2023-06-09 Lg Bionano Llc Metodos para preparar complejos de hierro.
CN112156109A (zh) 2020-09-29 2021-01-01 神奈纳米医药技术(珠海)有限公司 氢氧化铁-糖络合物的制备方法及其应用
CN115531414A (zh) 2021-06-30 2022-12-30 南京恒生制药有限公司 一种新型蔗糖铁复合物及其制备方法
JP2024534172A (ja) 2021-08-27 2024-09-18 ヴァイフォー（インターナショナル）アーゲー 鉄組成物並びにそれらを作製及び使用する方法

Similar Documents

Publication Publication Date Title
JP2025084949A5 (enExample)
JP2021063088A5 (enExample)
JP5470047B2 (ja) 抗ウイルス組成物及び使用方法
JP2009502355A5 (enExample)
JP2005511642A5 (enExample)
JP2006527762A5 (enExample)
PT2178533E (pt) Composição antiviral compreendendo um polissacarídeo sulfatado: iota-carragenina
JP2004529934A5 (enExample)
JP2023033538A5 (enExample)
JP2008526757A5 (enExample)
NO20090068L (no) Aktive agent formuleringer, fremstillingsmetoder, og anvendelsesmetoder
JP2005519914A5 (enExample)
ATE511847T1 (de) Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes
JPWO2020176894A5 (enExample)
HRP20230989T1 (hr) Novi sastavi željeza i metode njihove izrade i upotrebe
CN103908518B (zh) 一种治疗韦格纳肉芽肿病合并眶内假瘤的药物及其制备方法
JP2010506855A5 (enExample)
JP2019510788A5 (enExample)
WO2024093813A1 (zh) 核苷类化合物的制药用途
US20080131454A1 (en) Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
JP2014503592A5 (enExample)
JPWO2021251324A5 (enExample)
RU2009128724A (ru) Применение композиции, состоящей из низкомолекулярных фрагментов пептидогликана грам-отрицательных бактерий, для лечения и профилактики заболеваний человека
EP1930015A1 (en) Use of carrageenan for treating rhinovirus infections
WO2022115069A2 (en) Nasal solution with antiviral effect with its ph value